Qingdao Vland Biotech INC. (SHA:603739)

SHA:603739 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,352	1,282	1,177	1,135	1,110	936.23
Other Revenue	38.97	38.97	21.48	28.42	40.48	24.02
Revenue	1,391	1,321	1,199	1,163	1,151	960.25
Revenue Growth (YoY)	9.97%	10.16%	3.07%	1.07%	19.85%	13.40%
Cost of Revenue	764.87	728.42	648.46	662.86	620.4	495.66
Gross Profit	626.07	592.34	550.44	500.3	530.43	464.59
Selling, General & Admin	355.68	343.98	314.46	297.58	285	257.92
Research & Development	137.16	118.22	110.68	102.4	100.94	79.91
Other Operating Expenses	8.91	11.79	9.19	8.78	8.96	8.67
Operating Expenses	510.37	477.91	447.32	420.62	400.69	352.79
Operating Income	115.7	114.44	103.12	79.68	129.74	111.79
Interest Expense	-20.97	-21.88	-15.22	-7.17	-2.12	-1.78
Interest & Investment Income	-	1.53	8	3.93	7.91	6.09
Currency Exchange Gain (Loss)	0.47	0.47	0.58	3.21	-1.18	-2.3
Other Non Operating Income (Expenses)	-3.41	-2.97	-1.62	-8.46	-1.88	-0.45
EBT Excluding Unusual Items	91.78	91.58	94.87	71.18	132.46	113.35
Gain (Loss) on Sale of Investments	33.82	7.08	9.22	0.21	0.43	0.45
Gain (Loss) on Sale of Assets	-0.04	0.13	-0.25	0.29	-0.05	0.14
Asset Writedown	0.27	-0.07	-2.75	-	-	-0.68
Other Unusual Items	23.56	24.73	21.41	30.51	38.56	26.88
Pretax Income	149.39	123.44	122.5	102.19	171.4	140.15
Income Tax Expense	35.36	31.27	19.64	16.78	21.31	17.84
Earnings From Continuing Operations	114.03	92.17	102.86	85.41	150.1	122.3
Minority Interest in Earnings	-30.46	-29.53	-22.15	-15.57	-17.52	-13.33
Net Income	83.57	62.64	80.71	69.84	132.57	108.98
Net Income to Common	83.57	62.64	80.71	69.84	132.57	108.98
Net Income Growth	26.18%	-22.39%	15.56%	-47.32%	21.65%	40.16%
Shares Outstanding (Basic)	252	251	252	249	246	227
Shares Outstanding (Diluted)	252	251	252	259	246	227
Shares Change (YoY)	-1.15%	-0.66%	-2.50%	5.36%	8.14%	6.37%
EPS (Basic)	0.33	0.25	0.32	0.28	0.54	0.48
EPS (Diluted)	0.33	0.25	0.32	0.27	0.54	0.48
EPS Growth	27.65%	-21.88%	18.52%	-50.00%	12.50%	31.76%
Free Cash Flow	80.51	90.69	-62.05	-246.72	-404.06	-38.83
Free Cash Flow Per Share	0.32	0.36	-0.25	-0.95	-1.65	-0.17
Dividend Per Share	0.100	0.100	0.100	0.100	0.160	0.143
Dividend Growth	-	-	-	-37.50%	11.97%	-
Gross Margin	45.01%	44.85%	45.91%	43.01%	46.09%	48.38%
Operating Margin	8.32%	8.66%	8.60%	6.85%	11.27%	11.64%
Profit Margin	6.01%	4.74%	6.73%	6.00%	11.52%	11.35%
Free Cash Flow Margin	5.79%	6.87%	-5.18%	-21.21%	-35.11%	-4.04%
EBITDA	253.58	224.85	176.92	145.39	181.44	154.66
EBITDA Margin	18.23%	17.02%	14.76%	12.50%	15.77%	16.11%
D&A For EBITDA	137.88	110.41	73.79	65.71	51.7	42.87
EBIT	115.7	114.44	103.12	79.68	129.74	111.79
EBIT Margin	8.32%	8.66%	8.60%	6.85%	11.27%	11.64%
Effective Tax Rate	23.67%	25.33%	16.03%	16.42%	12.43%	12.73%
Revenue as Reported	1,391	1,321	1,199	1,163	1,151	960.25
Advertising Expenses	-	7.09	6.59	5.02	5.67	5.43

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.